These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND EML4, ENSG00000143924, 27436
23 results:

  • 1. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
    Wu S; Liu Y; Shi X; Zhou W; Zeng X
    Dig Liver Dis; 2023 Dec; 55(12):1757-1764. PubMed ID: 37142453
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutations in Classical Signaling Pathways and Their Functional Impact in Microsatellite Instability High colorectal cancer.
    Shi S; Gong Y; Li X; Ding Y; Song G; Liu H; Zhang Z
    Genet Test Mol Biomarkers; 2023 Mar; 27(3):90-99. PubMed ID: 36989521
    [No Abstract]    [Full Text] [Related]  

  • 3. Molecular characterization of adenocarcinomas arising in the urinary bladder following augmentation cystoplasty: a multi-institutional study.
    Stohr BA; Chan E; Anderson JA; Matoso A; Murati Amador BI; Cheng L; Osunkoya AO
    Hum Pathol; 2022 Nov; 129():98-102. PubMed ID: 36108931
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas.
    Zhang Z; Pang J; Chen L; Chen J; Li J; Liu H; Wang J; Wu H; Liang Z
    Hum Pathol; 2022 Nov; 129():21-31. PubMed ID: 35977594
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
    J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic cancers.
    Tsang ES; Grisdale CJ; Pleasance E; Topham JT; Mungall K; Reisle C; Choo C; Carreira M; Bowlby R; Karasinska JM; MacMillan D; Williamson LM; Chuah E; Moore RA; Mungall AJ; Zhao Y; Tessier-Cloutier B; Ng T; Sun S; Lim HJ; Schaeffer DF; Renouf DJ; Yip S; Laskin J; Marra MA; Jones SJM; Loree JM
    Clin Cancer Res; 2021 Jan; 27(2):522-531. PubMed ID: 33148671
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature.
    Lasota J; Chłopek M; Wasąg B; Kowalik A; Christiansen J; Lamoureux J; Kuźniacka A; Felisiak-Gołąbek A; Liu Y; Reyes TAR; Saha R; Agaimy A; Behenska K; Biernat W; Cattaneo L; Centonze G; Daum O; Daumova M; Domagała P; Dziuba I; Geppert CE; Góźdź S; Nasierowska-Guttmejer A; Hałoń A; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kaczorowski M; Kołos M; Kopczyński J; Michal M; Milione M; Okoń K; Pęksa R; Pyzlak M; Ryś J; Waloszczyk P; Wejman J; Miettinen M
    Am J Surg Pathol; 2020 Sep; 44(9):1224-1234. PubMed ID: 32804454
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature.
    Lasota J; Chłopek M; Lamoureux J; Christiansen J; Kowalik A; Wasąg B; Felisiak-Gołąbek A; Agaimy A; Biernat W; Canzonieri V; Centonze G; Chmielik E; Daum O; Dubová M; Dziuba I; Goertz S; Góźdź S; Guttmejer-Nasierowska A; Haglund C; Hałoń A; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kaczorowski M; Kita P; Kołos M; Kopczyński J; Michal M; Milione M; Okoń K; Pęksa R; Pyzlak M; Ristimäki A; Ryś J; Szostak B; Szpor J; Szumiło J; Teresiński L; Waloszczyk P; Wejman J; Wesołowski W; Miettinen M
    Am J Surg Pathol; 2020 Feb; 44(2):162-173. PubMed ID: 31567189
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genomic Alterations Observed in Colitis-Associated cancers Are Distinct From Those Found in Sporadic colorectal cancers and Vary by Type of Inflammatory Bowel Disease.
    Yaeger R; Shah MA; Miller VA; Kelsen JR; Wang K; Heins ZJ; Ross JS; He Y; Sanford E; Yantiss RK; Balasubramanian S; Stephens PJ; Schultz N; Oren M; Tang L; Kelsen D
    Gastroenterology; 2016 Aug; 151(2):278-287.e6. PubMed ID: 27063727
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Oncogenic ALK Fusion in Rare and Aggressive Subtype of colorectal Adenocarcinoma as a Potential Therapeutic Target.
    Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H
    Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Haplotyping germline and cancer genomes with high-throughput linked-read sequencing.
    Zheng GX; Lau BT; Schnall-Levin M; Jarosz M; Bell JM; Hindson CM; Kyriazopoulou-Panagiotopoulou S; Masquelier DA; Merrill L; Terry JM; Mudivarti PA; Wyatt PW; Bharadwaj R; Makarewicz AJ; Li Y; Belgrader P; Price AD; Lowe AJ; Marks P; Vurens GM; Hardenbol P; Montesclaros L; Luo M; Greenfield L; Wong A; Birch DE; Short SW; Bjornson KP; Patel P; Hopmans ES; Wood C; Kaur S; Lockwood GK; Stafford D; Delaney JP; Wu I; Ordonez HS; Grimes SM; Greer S; Lee JY; Belhocine K; Giorda KM; Heaton WH; McDermott GP; Bent ZW; Meschi F; Kondov NO; Wilson R; Bernate JA; Gauby S; Kindwall A; Bermejo C; Fehr AN; Chan A; Saxonov S; Ness KD; Hindson BJ; Ji HP
    Nat Biotechnol; 2016 Mar; 34(3):303-11. PubMed ID: 26829319
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract cancer: Implication for Targeted Therapy in Chinese Population.
    Ying J; Lin C; Wu J; Guo L; Qiu T; Ling Y; Shan L; Zhou H; Zhao D; Wang J; Liang J; Zhao J; Jiao Y; Lu N; Zhao H
    PLoS One; 2015; 10(12):e0144731. PubMed ID: 26678488
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening.
    Lee J; Kim HC; Hong JY; Wang K; Kim SY; Jang J; Kim ST; Park JO; Lim HY; Kang WK; Park YS; Lee J; Lee WY; Park YA; Huh JW; Yun SH; Do IG; Kim SH; Balasubramanian S; Stephens PJ; Ross JS; Li GG; Hornby Z; Ali SM; Miller VA; Kim KM; Ou SH
    Oncotarget; 2015 Sep; 6(27):24320-32. PubMed ID: 26172300
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ALK and ROS1 overexpression is very rare in colorectal adenocarcinoma.
    Houang M; Toon CW; Clarkson A; Sioson L; de Silva K; Watson N; Singh NR; Chou A; Gill AJ
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):134-8. PubMed ID: 24992173
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.
    Aisner DL; Nguyen TT; Paskulin DD; Le AT; Haney J; Schulte N; Chionh F; Hardingham J; Mariadason J; Tebbutt N; Doebele RC; Weickhardt AJ; Varella-Garcia M
    Mol Cancer Res; 2014 Jan; 12(1):111-8. PubMed ID: 24296758
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients.
    Jiang L; Huang J; Morehouse C; Zhu W; Korolevich S; Sui D; Ge X; Lehmann K; Liu Z; Kiefer C; Czapiga M; Su X; Brohawn P; Gu Y; Higgs BW; Yao Y
    Cancer Genet; 2013; 206(9-10):330-9. PubMed ID: 24200637
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Personalized oncology in interventional radiology.
    Abi-Jaoudeh N; Duffy AG; Greten TF; Kohn EC; Clark TW; Wood BJ
    J Vasc Interv Radiol; 2013 Aug; 24(8):1083-92; quiz 1093. PubMed ID: 23885909
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation.
    Chung C; Christianson M
    J Oncol Pharm Pract; 2014 Feb; 20(1):11-28. PubMed ID: 23493335
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.
    Karkouche R; Bachet JB; Sandrini J; Mitry E; Penna C; Côté JF; Blons H; Penault-Llorca F; Rougier P; Saint André JP; Emile JF
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1430-7. PubMed ID: 23114745
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.